Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 438,000 | 338,000 | 319,000 | 350,000 | 903,000 |
| Receivables | 1,387,000 | 1,291,000 | 1,275,000 | 1,274,000 | 1,195,000 |
| Inventories | 981,000 | 1,022,000 | 1,016,000 | 1,086,000 | 968,000 |
| Income taxes - deferred | 78,000 | 76,000 | 496,000 | 367,000 | 316,000 |
| Other current assets | 446,000 | 437,000 | 365,000 | 385,000 | 391,000 |
| TOTAL | $3,330,000 | $3,164,000 | $3,471,000 | $3,462,000 | $3,773,000 |
| Non-Current Assets | |||||
| PPE Net | 1,487,000 | 1,464,000 | 1,490,000 | 1,479,000 | 1,451,000 |
| Intangibles | 12,405,000 | 12,539,000 | 12,667,000 | 12,696,000 | 11,372,000 |
| Other Non-Current Assets | 616,000 | 551,000 | 505,000 | 578,000 | 527,000 |
| TOTAL | $14,508,000 | $14,554,000 | $14,662,000 | $14,753,000 | $13,350,000 |
| Total Assets | $17,838,000 | $17,718,000 | $18,133,000 | $18,215,000 | $17,123,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 254,000 | 253,000 | 3,000 | 63,000 | 43,000 |
| Accounts payable and accrued liabilities | 284,000 | 232,000 | 209,000 | 210,000 | 191,000 |
| Accrued Expenses | 2,236,000 | 1,792,000 | 1,970,000 | 1,605,000 | 1,401,000 |
| Other current liabilities | 408,000 | 331,000 | 248,000 | 360,000 | 302,000 |
| TOTAL | $3,182,000 | $2,608,000 | $2,430,000 | $2,238,000 | $1,937,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,173,000 | 5,424,000 | 5,674,000 | 5,796,000 | 5,069,000 |
| Other Non-Current Liabilities | 3,239,000 | 2,934,000 | 2,974,000 | 3,001,000 | 2,638,000 |
| TOTAL | $8,436,000 | $8,653,000 | $9,383,000 | $9,567,000 | $8,606,000 |
| Total Liabilities | $11,618,000 | $11,261,000 | $11,813,000 | $11,805,000 | $10,543,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,360,743 | 1,356,867 | 1,348,346 | 1,345,195 | 1,343,957 |
| Common Shares | 18,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -8,934,000 | -8,725,000 | -8,927,000 | -8,785,000 | -8,587,000 |
| Other shareholders' equity | -70,000 | 35,000 | 88,000 | 81,000 | 104,000 |
| TOTAL | $6,220,000 | $6,457,000 | $6,320,000 | $6,410,000 | $6,580,000 |
| Total Liabilities And Equity | $17,838,000 | $17,718,000 | $18,133,000 | $18,215,000 | $17,123,000 |